Related references
Note: Only part of the references are listed.Oxidative stress-CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway
Jiaqi Jin et al.
NUCLEIC ACIDS RESEARCH (2022)
Circular RNA circ_0067741 regulates the Hippo/YAP pathway to suppress lung adenocarcinoma progression by targeting microRNA-183-5p
Jianming Mo et al.
BIOENGINEERED (2022)
SIRPγ-expressing cancer stem-like cells promote immune escape of lung cancer via Hippo signaling
Chuan Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Hypoxic bone marrow mesenchymal cell-extracellular vesicles containing miR-328-3p promote lung cancer progression via the NF2-mediated Hippo axis
Xi Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling
Kang-Yun Lee et al.
CELLS (2021)
Curcumin suppresses the stemness of non-small cell lung cancer cells via promoting the nuclear-cytoplasm translocation of TAZ
Yuzhen Zheng et al.
ENVIRONMENTAL TOXICOLOGY (2021)
miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer
Bowen Zhu et al.
CANCERS (2021)
LncRNA SFTA1P mediates positive feedback regulation of the Hippo-YAP/TAZ signaling pathway in non-small cell lung cancer
Bowen Zhu et al.
CELL DEATH DISCOVERY (2021)
WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression
Qiang Han et al.
CELL DEATH & DISEASE (2021)
Aqueous extract of Taxus chinensis var. mairei regulates the Hippo-YAP pathway and promotes apoptosis of non-small cell lung cancer via ATF3 in vivo and in vitro
Gaochenxi Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways
Man Yang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non-small cell lung cancer
Yijun Zhang et al.
MOLECULAR MEDICINE REPORTS (2021)
MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway
Wenbin Liu et al.
ONCOGENE (2021)
The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation
Wensheng Wang et al.
PHARMACOLOGICAL RESEARCH (2021)
Tumor-derived exosomal miR-19b-3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway
Jing Chen et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis
Yi-Wen Zheng et al.
FRONTIERS IN ONCOLOGY (2020)
CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer
Yulan Zeng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
MicroRNA-188 inhibits biological activity of lung cancer stem cells through targeting MDK and mediating the Hippo pathway
Xiaolin Yang et al.
EXPERIMENTAL PHYSIOLOGY (2020)
Sophoridine inhibits lung cancer cell growth and enhances cisplatin sensitivity through activation of the p53 and Hippo signaling pathways
Lingling Zhu et al.
GENE (2020)
Cryptotanshinone attenuates the stemness of non-small cell lung cancer cells via promoting TAZ translocation from nuclear to cytoplasm
Linling Jin et al.
CHINESE MEDICINE (2020)
Hippo pathway and tumoral FOXP3 expression correlate with tumor growth in squamous cell carcinoma of the lung
Kyu Yeoun Won et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Distinct transcriptional programs of SOX2 in different types of small cell lung cancers
Yuki Tenjin et al.
LABORATORY INVESTIGATION (2020)
Nitidine chloride possesses anticancer property in lung cancer cells through activating Hippo signaling pathway
Jing Zhang et al.
CELL DEATH DISCOVERY (2020)
Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1
Wei Zhao et al.
FASEB JOURNAL (2019)
Yap-Hippo promotes A549 lung cancer cell death via modulating MIEF1-related mitochondrial stress and activating JNK pathway
Jiayu Zho et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Analysis of the role of the Hippo pathway in cancer
Yanyan Han
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Dysfunction of the Hippo-Yap Pathway Drives Lung Cancer Metastasis Induced by 1-Nitropyrene through Adhesion Molecular Activation
Rui Gao et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY LETTERS (2019)
FRMPD1 activates the Hippo pathway via interaction with WWC3 to suppress the proliferation and invasiveness of lung cancer cells
Xuezhu Rong et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Hippo Signaling in Cancer: Lessons From Drosophila Models
Kirti Snigdha et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
PM2.5-associated nitro-PAH exposure promotes tumor cell metastasis through Hippo-YAP mediated transcriptional regulation
Rui Gao et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2019)
The Hippo Pathway: Biology and Pathophysiology
Shenghong Ma et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88 (2019)
The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer
Tingting Lu et al.
CANCER LETTERS (2018)
The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1
Helena J. Janse van Rensburg et al.
CANCER RESEARCH (2018)
Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway
Chun-Hui Zheng et al.
CELL BIOLOGY INTERNATIONAL (2018)
Down-regulation of TYK2, CBLB and LMP7 genes expression in relapsing-remitting multiple sclerosis patients treated with interferon-beta
Mehrdokht Mazdeh et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
WWC3 inhibits epithelial-mesenchymal transition of lung cancer by activating Hippo-YAP signaling
Qiang Han et al.
ONCOTARGETS AND THERAPY (2018)
A Plasma Long Noncoding RNA Signature for Early Detection of Lung Cancer
Yanli Lin et al.
TRANSLATIONAL ONCOLOGY (2018)
Long noncoding RNA CASC9/miR-519d/STAT3 positive feedback loop facilitate the glioma tumourigenesis
Hongjiang Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells
Yuyuan Dai et al.
ONCOTARGET (2017)
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
A. Noto et al.
ONCOGENE (2017)
Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer
Qianze Dong et al.
ONCOTARGET (2017)
The Emerging Role of the Hippo Pathway in Lung Cancers: Clinical Implications
Seong Lin Teoh et al.
CURRENT DRUG TARGETS (2017)
Can IncRNAs Be Indicators for the Diagnosis of Early Onset or Acute Schizophrenia and Distinguish Major Depressive Disorder and Generalized Anxiety Disorder?-A Cross Validation Analysis
Xuelian Cui et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)
Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance
Jeong Eun Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway
Ruixiang Tang et al.
BRITISH JOURNAL OF CANCER (2016)
Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling
Nicholas Nelson et al.
ONCOTARGET (2016)
YAP promotes erlotinib resistance in human non-small cell lung cancer cells
Ping-Chih Hsu et al.
ONCOTARGET (2016)
The regulation and function of YAP transcription co-activator
Chu Zhu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2015)
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
Krishna P. L. Bhat et al.
GENES & DEVELOPMENT (2011)
Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
Chad A. Hall et al.
CANCER RESEARCH (2010)
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins
F Kanai et al.
EMBO JOURNAL (2000)
Share Paper
